These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20590862)

  • 1. Tests of global haemostasis and their applications in bleeding disorders.
    Nair SC; Dargaud Y; Chitlur M; Srivastava A
    Haemophilia; 2010 Jul; 16 Suppl 5():85-92. PubMed ID: 20590862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardization and clinical utility of thrombin-generation assays.
    Berntorp E; Salvagno GL
    Semin Thromb Hemost; 2008 Oct; 34(7):670-82. PubMed ID: 19085768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Manageability and potential for haemostasis monitoring by near-patient modified thromboelastometer (Rotem) in intensive care unit].
    Savry C; Quinio P; Lefèvre F; Schmitt F
    Ann Fr Anesth Reanim; 2005 Jun; 24(6):607-16. PubMed ID: 15922540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Underestimation of plasma level of factor V coagulant activity and fibrinogen concentration together with prolonged prothrombin time, activated partial thromboplastin time and thrombin time can result from pre-analytical very low calcium level in citrated sample tube.
    d'Audigier C; Delassasseigne C; Robert A; Eschwège V
    Int J Lab Hematol; 2016 Feb; 38(1):50-3. PubMed ID: 26406495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of activated partial thromboplastin time clot waveform analysis and thrombin generation test in the evaluation of bleeding phenotype in Hemophilia A.
    Dave RG; Geevar T; Mammen JJ; Vijayan R; Mahasampath G; Nair SC
    Indian J Pathol Microbiol; 2021; 64(1):117-122. PubMed ID: 33433420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitor.
    Samama MM; Martinoli JL; LeFlem L; Guinet C; Plu-Bureau G; Depasse F; Perzborn E
    Thromb Haemost; 2010 Apr; 103(4):815-25. PubMed ID: 20135059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endogenous thrombin potential in practical use].
    Wilkens M
    Hamostaseologie; 2011 May; 31(2):88-93. PubMed ID: 21152675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboelastometric (ROTEM) findings in patients suffering from isolated severe traumatic brain injury.
    Schöchl H; Solomon C; Traintinger S; Nienaber U; Tacacs-Tolnai A; Windhofer C; Bahrami S; Voelckel W
    J Neurotrauma; 2011 Oct; 28(10):2033-41. PubMed ID: 21942848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of using thrombin generation assay (TGA) for monitoring of haemostasis during supplementation therapy in haemophilic patients without inhibitors.
    Ay Y; Balkan C; Karapinar DY; Akin M; Bilenoğlu B; Kavakli K
    Haemophilia; 2012 Nov; 18(6):911-6. PubMed ID: 22639879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations between global clotting function tests, duration of operation, and postoperative chest tube drainage in pediatric cardiac surgery.
    Hayashi T; Sakurai Y; Fukuda K; Yada K; Ogiwara K; Matsumoto T; Yoshizawa H; Takahashi Y; Yoshikawa Y; Hayata Y; Taniguchi S; Shima M
    Paediatr Anaesth; 2011 Aug; 21(8):865-71. PubMed ID: 21251146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin generation.
    Berry LR; Chan AK
    Methods Mol Biol; 2013; 992():139-54. PubMed ID: 23546711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in the laboratory analyses of bleeding disorders.
    Chitlur M
    Thromb Res; 2012 Jul; 130(1):1-6. PubMed ID: 22483776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls.
    Collins PW; Macchiavello LI; Lewis SJ; Macartney NJ; Saayman AG; Luddington R; Baglin T; Findlay GP
    Br J Haematol; 2006 Oct; 135(2):220-7. PubMed ID: 17010048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of haemostasis in liver transplantation: comparison of laboratory based and point of care tests.
    Herbstreit F; Winter EM; Peters J; Hartmann M
    Anaesthesia; 2010 Jan; 65(1):44-9. PubMed ID: 19889111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global haemostasis and point of care testing.
    Dargaud Y; Sorensen B; Shima M; Hayward C; Srivastava A; Negrier C
    Haemophilia; 2012 Jul; 18 Suppl 4():81-8. PubMed ID: 22726088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of haemolysis, lipaemia and bilirubinaemia on prothrombin time, activated partial thromboplastin time and thrombin time in plasma samples from healthy dogs.
    Moreno P; Ginel PJ
    Res Vet Sci; 1999 Dec; 67(3):273-6. PubMed ID: 10607508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global haemostasis assays, from bench to bedside.
    van Geffen M; van Heerde WL
    Thromb Res; 2012 Jun; 129(6):681-7. PubMed ID: 22221936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital.
    Chng WJ; Sum C; Kuperan P
    Singapore Med J; 2005 Sep; 46(9):450-6. PubMed ID: 16123828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired coagulation disorders: revisited using global coagulation/anticoagulation testing.
    Tripodi A; Chantarangkul V; Mannucci PM
    Br J Haematol; 2009 Oct; 147(1):77-82. PubMed ID: 19659548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.